{"date":"2025-09-12","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6919-2025-09-12-2021-rydi9v","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-12","time":"20:21:36","subject":"公告本公司董事會決議修訂「113年度限制員工權利新股發行辦法」","clause":"第11款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-12 20:21，「公告本公司董事會決議修訂「113年度限制員工權利新股發行辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-09-12-2021-dyoqpd","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-12","time":"20:21:21","subject":"公告本公司董事會決議修訂「113年度員工認股權憑證發行及認股辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-12 20:21，「公告本公司董事會決議修訂「113年度員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-09-12-2020-1tupuf1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-09-12","time":"20:20:49","subject":"公告本公司董事會決議修訂「109~111年度員工認股權憑證發行及認股辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-09-12 20:20，「公告本公司董事會決議修訂「109~111年度員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2025-09-12-1830-1davfpi","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2025-09-12","time":"18:30:05","subject":"本公司接獲晶碩提出請求撤銷專利權之訴訟","clause":"第2款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2025-09-12 18:30，「本公司接獲晶碩提出請求撤銷專利權之訴訟」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-09-12-1708-9acjsf","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-09-12","time":"17:08:59","subject":"依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"第22款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-09-12 17:08，「依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2025-09-12-1621-sqgrt0","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2025-09-12","time":"16:21:49","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2025-09-12 16:21，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2025-09-12-1604-1v75o42","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2025-09-12","time":"16:04:45","subject":"公告本公司限制員工權利新股收回註銷減資變更登記完成","clause":"第35款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2025-09-12 16:04，「公告本公司限制員工權利新股收回註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2025-09-12-1602-9chjfu","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2025-09-12","time":"16:02:06","subject":"公告本公司第7次買回庫藏股執行完畢","clause":"第35款","fact_date":"2025-09-27","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2025-09-12 16:02，「公告本公司第7次買回庫藏股執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-09-12-1528-bbryfi","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-12","time":"15:28:25","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，分別取得日本及加拿大發明專利","clause":"第44款","fact_date":"2025-09-12","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-09-12 15:28，「公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，分別取得日本及加拿大發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-09-12-1526-1jia6er","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-09-12","time":"15:26:33","subject":"公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上巿交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-09-12 15:26，「公告本公司股票即將終止興櫃交易並轉至臺灣證券交易所上巿交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}